FDA sob nova administração

O Congresso americano agora com maioria do Partido Democrata está atacando um dos maiores problemas na área da saúde, o Food and Drug Administration, o famoso FDA. Artigo na edição do The Wall Street Journal mostra as várias propostas em votação.

Congress is kicking off efforts to pass big reforms of the Food and Drug Administration, and that could produce some bitter pills for the pharmaceutical industry: potentially, tougher safety rules and provisions to reduce the cost of medicines. Yesterday, Sen. Edward Kennedy of Massachusetts and Sen. Michael Enzi of Wyoming, the chairman and ranking Republican of the health committee, respectively, introduced legislation that would give the FDA new authority to impose safety requirements on medicines once they go on the market, including restrictions on consumer advertising. The bill also would require registration of clinical drug trials and their results in public databases.